Aller directement au menu principal Aller directement au contenu principal Aller au pied de page

Cortica explique-moi

Vol. 2 No. 2 (2023): OPEN SCIENCE : Accès aux savoirs scientifiques auprès des professionnels de santé et contribuer à la littératie scientifique citoyenne

Aperçu sur l’Ecstasy

  • Deborah Chiarotto
  • Sineka Rajaratnam
DOI
https://doi.org/10.26034/cortica.2023.4170
Soumise
August 28, 2023
Publié-e
2023-09-19

Résumé

Aperçu sur l’Ecstasy

Références

  1. Bedi, G., Hyman, D., & de Wit, H. (2010). Is ecstasy an “empathogen”? Effects of±3, 4- methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biological psychiatry, 68(12), 1134-1140. https://doi.org/10.1016/j.biopsych.2010.08.003
  2. Cohen, R. S. (1995). Subjective reports on the effects of the MDMA (" ecstasy") experience in humans. Progress in neuro-psychopharmacology & biological psychiatry. https://doi.org/10.1016/0278-5846(95)00231-6
  3. Critcher, C. (2000). ‘Still raving’: Social reaction to ecstasy. Leisure Studies, 19(3), 145-162. https://doi.org/10.1080/02614360050023053
  4. de Win, M. M., Jager, G., Booij, J., Reneman, L., Schilt, T., Lavini, C., ... & van den Brink, W. (2008). Neurotoxic effects of ecstasy on the thalamus. The British Journal of Psychiatry, 193(4), 289-296. https://doi.org/10.1192/bjp.bp.106.035089
  5. Dumont, G. J., Sweep, F. C. G. J., Van der Steen, R., Hermsen, R., Donders, A. R. T., Touw, D. J., ... & Verkes, R. J. (2009). Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3, 4-methylenedioxymethamphetamine) administration. Social neuroscience, 4(4), 359-366. https://doi.org/10.1080/17470910802649470
  6. Gowing, L. R., HENRY‐EDWARDS, S. M., Irvine, R. J., & Ali, R. L. (2002). The health effects of ecstasy: a literature review. Drug and alcohol review, 21(1), 53-63. https://doi.org/10.1080/09595230220119363
  7. Morgan, M. J. (2000). Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology, 152, 230-248. https://doi.org/10.1007/s002130000545
  8. Peters, G. J. Y., Kok, G., & Abraham, C. (2008). Social cognitive determinants of ecstasy use to target in evidence‐based interventions: a meta‐analytical review. Addiction, 103(1), 109-118. https://doi.org/10.1111/j.1360-0443.2007.02041.x
  9. Schilt, T., de Win, M. M., Jager, G., Koeter, M. W., Ramsey, N. F., Schmand, B., & van den Brink, W. (2008). Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychological medicine, 38(9), 1309-1317. https://doi.org/10.1017/S0033291707002140
  10. Soar, K., Turner, J. J. D., & Parrott, A. C. (2001). Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history. Human Psychopharmacology: Clinical and Experimental, 16(8), 641-645. https://doi.org/10.1002/hup.350
  11. Thompson, M. R., Hunt, G. E., & McGregor, I. S. (2009). Neural correlates of MDMA (“Ecstasy”)-induced social interaction in rats. Social neuroscience, 4(1), 60-72. https://doi.org/10.1080/17470910802045042
  12. Wardle, M. C., Kirkpatrick, M. G., & de Wit, H. (2014). ‘Ecstasy’as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Social cognitive and affective neuroscience, 9(8), 1076-1081. https://doi.org/10.1093/scan/nsu035